clonazepam has been researched along with olanzapine in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (37.93) | 29.6817 |
| 2010's | 15 (51.72) | 24.3611 |
| 2020's | 3 (10.34) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kumar, R | 1 |
| Jones, C; Kapur, S; Remington, G; Tauscher, J; Zipursky, RB | 1 |
| Gastfriend, DR; Sattar, SP | 1 |
| Schenck, CH | 1 |
| Imran, N; Rampes, H; Rosen, S | 1 |
| Sicot, R | 1 |
| Csonka, A; Makkos, Z | 1 |
| Miller, KM; Murray, KL; Pearson, DL | 1 |
| Inada, T; Oda, T; Yamamoto, N | 1 |
| Salo, R; Wolf, J | 1 |
| Coburn, KL; Doonan, SM; Lauterbach, EC; Mendez, MF; Shillcutt, SD; Victoroff, J | 1 |
| Işik, U; Korkmaz, H; Korkmaz, S | 1 |
| Ferencz, C; Fullajtar, M | 1 |
| Askenazy, F; Drici, M; Lavrut, T; Menard, ML; Yagoubi, F | 1 |
| Aldana-Bernier, L; Bhojani, S; Pawelzik, T; Sikder, M | 1 |
| Kumar, A; Verma, A | 1 |
| Ambaliya, A; Dosi, R; Joshi, H; Patell, R | 1 |
| Akhondzadeh, S; Bigdeli, M; Ghanizadeh, A; Sahraian, A | 1 |
| Aragones, JM; Blanch, CE; Escote-Llobet, S; Guillen-Font, A | 1 |
| Belhaj, A; Ben Youssef, H; Bouasker, A; Bouden, A; Ghachem, R; Halayem, S; Othman, S; Tabbane, K | 1 |
| Ghanizadeh, A; Jahromi, LR; Mowla, A; Sahraian, A | 1 |
| Lochhead, JD; Maguire, GA; Nelson, MA | 1 |
| Kanwar, P; Kumar, R; Sharma, RC | 1 |
| Haboubi, H; Mawhinney, JA; Roshanzamir, S; Wilcock, C | 1 |
| Deguchi, Y; Inoue, K; Itoh, Y; Sakamoto, S; Uchida, S | 1 |
| Chen, J; Guo, X; Jiang, B; Liang, B; Wang, W | 1 |
3 review(s) available for clonazepam and olanzapine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Brain; Clonazepam; Desipramine; Dibenzothiazepines; Dopamine Agonists; Humans; Lithium Carbonate; Maprotiline; Melatonin; Neurodegenerative Diseases; Neuroprotective Agents; Olanzapine; Parkinson Disease; Pramipexole; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Valproic Acid | 2010 |
Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Clonazepam; Diagnosis, Differential; GABA Modulators; Humans; Lithium Compounds; Male; Neuroleptic Malignant Syndrome; Olanzapine; Risperidone; Serotonin Syndrome; Valproic Acid; Young Adult | 2014 |
2 trial(s) available for clonazepam and olanzapine
| Article | Year |
|---|---|
Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: a randomized double blind placebo controlled clinical trial.
Topics: Adult; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Clonazepam; Double-Blind Method; Drug Therapy, Combination; Female; Fructose; Humans; Lithium Compounds; Male; Middle Aged; Neuroprotective Agents; Obsessive-Compulsive Disorder; Olanzapine; Selective Serotonin Reuptake Inhibitors; Topiramate; Treatment Outcome | 2014 |
Memantine as an Adjuvant Treatment for Obsessive Compulsive Symptoms in Manic Phase of Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Topics: Adjuvants, Pharmaceutic; Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clonazepam; Double-Blind Method; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; GABA Modulators; Humans; Lithium Compounds; Male; Memantine; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Outcome Assessment, Health Care | 2017 |
24 other study(ies) available for clonazepam and olanzapine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Acute severe catatonia in a young woman with chronic schizophrenia responding to parenteral clonazepam.
Topics: Acute Disease; Adult; Benzodiazepines; Clonazepam; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Olanzapine; Pirenzepine; Schizophrenia, Catatonic | 2001 |
Significant dissociation of brain and plasma kinetics with antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood-Brain Barrier; Brain; Carbon Radioisotopes; Clonazepam; Corpus Striatum; Female; Half-Life; Humans; Kinetics; Male; Olanzapine; Pirenzepine; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Reference Values; Schizophrenia; Tomography, Emission-Computed | 2002 |
Visual inspection of medications in preventing unexplained relapses.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Aspirin; Benzodiazepines; Cetirizine; Clonazepam; Depression; Female; Humans; Medication Errors; Middle Aged; Olanzapine; Pirenzepine; Secondary Prevention; Terminology as Topic | 2002 |
Restless legs syndrome and periodic limb movements of sleep: global therapeutic considerations.
Topics: Anticonvulsants; Benzodiazepines; Clonazepam; Humans; Nocturnal Myoclonus Syndrome; Olanzapine; Pirenzepine; Restless Legs Syndrome; Selective Serotonin Reuptake Inhibitors; Sleep, REM | 2002 |
Antipsychotic induced prolongation of QTc interval treated with magnesium.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clonazepam; Electrocardiography; Humans; Long QT Syndrome; Magnesium; Male; Olanzapine | 2003 |
[Love, humor and psychosis in an atypical depression].
Topics: Antidepressive Agents; Antipsychotic Agents; Azabicyclo Compounds; Benzodiazepines; Clonazepam; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Hypnotics and Sedatives; Love; Olanzapine; Piperazines; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Wit and Humor as Topic | 2005 |
[Akathisia in the course of olanzapine treatment].
Topics: Aged; Akathisia, Drug-Induced; Anticonvulsants; Antipsychotic Agents; Azabicyclo Compounds; Benzodiazepines; Clonazepam; Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Olanzapine; Patient Admission; Piperazines; Schizophrenia; Treatment Outcome | 2006 |
Neonatal withdrawal syndrome following in utero exposure to paroxetine, clonazepam and olanzapine.
Topics: Antidepressive Agents, Second-Generation; Benzodiazepines; Clonazepam; Humans; Infant, Newborn; Male; Neonatal Abstinence Syndrome; Olanzapine; Paroxetine; Respiratory Insufficiency; Serotonin Syndrome | 2007 |
Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam.
Topics: Aged; Anti-Dyskinesia Agents; Antipsychotic Agents; Benzodiazepines; Biperiden; Central Nervous System Stimulants; Clonazepam; Dyskinesia, Drug-Induced; Hallucinations; Haloperidol; Humans; Male; Methamphetamine; Olanzapine; Posture; Psychoses, Substance-Induced; Risperidone | 2007 |
Water, water, everywhere, nor any drop to drink: climate change delusion.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Climate; Clonazepam; Dehydration; Delusions; Depressive Disorder; Fluoxetine; GABA Modulators; Greenhouse Effect; Humans; Male; Olanzapine; Psychotic Disorders; Water Supply | 2008 |
Raynaud’s phenomenon in a patient with schizophrenia and obsessive-compulsive disorder: a case report.
Topics: Amlodipine; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Clonazepam; Drug Therapy, Combination; Fluoxetine; GABA Modulators; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Raynaud Disease; Schizophrenia; Vasodilator Agents | 2011 |
[Designer drug induced psychosis].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Benzodioxoles; Clonazepam; Designer Drugs; Drug Therapy, Combination; Humans; Hungary; Male; Olanzapine; Psychoses, Substance-Induced; Psychotropic Drugs; Pyrrolidines; Risperidone; Substance Abuse Detection; Synthetic Cathinone | 2012 |
[Follow-up of a 16-year-old adolescent with early-onset schizophrenia and catatonic symptoms].
Topics: Adolescent; Benzodiazepines; Carbamazepine; Clonazepam; Clozapine; Creatine Kinase; Diagnosis, Differential; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Humans; Lorazepam; Male; Olanzapine; Patient Admission; Psychiatric Status Rating Scales; Psychometrics; Recurrence; Risperidone; Schizophrenia, Catatonic | 2013 |
Psychotic disorder after contact with a potentially rabid animal and post-exposure prophylactic anti-rabies treatment.
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Clonazepam; Diagnosis, Differential; Dibenzothiazepines; Female; Haloperidol; Humans; Lorazepam; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Rabies; Rabies Vaccines; Young Adult | 2014 |
Neurocysticercosis presenting as acute psychosis: a rare case report from rural India.
Topics: Acetazolamide; Adult; Antipsychotic Agents; Benzodiazepines; Brain; Clonazepam; Glucocorticoids; Humans; India; Magnetic Resonance Imaging; Male; Neurocysticercosis; Olanzapine; Prednisolone; Treatment Outcome | 2013 |
[Buccolingual dyskinesia with justified hallucinations].
Topics: Alcoholism; Benzodiazepines; Clonazepam; Depressive Disorder; Dibenzothiazepines; Disulfiram; Female; Fluoxetine; Foreign Bodies; Hallucinations; Humans; Middle Aged; Movement Disorders; Olanzapine; Pharynx; Quetiapine Fumarate; Tetrabenazine; Tongue Habits | 2014 |
[The Usefulness of Clonazepam as an Augmentative Treatment in a Case of Severe Childhood Onset Obsessive-Compulsive Disorder].
Topics: Adolescent; Benzodiazepines; Clonazepam; Drug Therapy, Combination; Female; GABA Modulators; Humans; Obsessive-Compulsive Disorder; Olanzapine; Sertraline; Severity of Illness Index; Turkey | 2015 |
Anti-NMDA receptor encephalitis presenting as a primary psychotic disorder.
Topics: Adolescent; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antipsychotic Agents; Autoantibodies; Clonazepam; Diagnosis, Differential; Female; Humans; Olanzapine; Psychotic Disorders; Receptors, N-Methyl-D-Aspartate | 2017 |
Cannabis induced koro in a Nepali migrant.
Topics: Adult; Cannabis; Citalopram; Clonazepam; GABA Modulators; Humans; Koro; Male; Nepal; Olanzapine; Selective Serotonin Reuptake Inhibitors; Transients and Migrants | 2018 |
Neurotropism of SARS-CoV-2: COVID-19 presenting with an acute manic episode.
Topics: Adult; Affective Symptoms; Betacoronavirus; Cerebrospinal Fluid; Clonazepam; Coronavirus Infections; COVID-19; Diagnosis, Differential; Emergency Medical Services; Headache; Humans; Male; Neuroimaging; Olanzapine; Pandemics; Pneumonia, Viral; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Psychotropic Drugs; SARS-CoV-2; Treatment Outcome | 2020 |
Prolonged extrapyramidal symptoms induced by long-term, intermittent administration of low-dose olanzapine along with metoclopramide for emesis: A case report.
Topics: Antiemetics; Antineoplastic Agents; Antipsychotic Agents; Biperiden; Clonazepam; Dopamine; Humans; Male; Metoclopramide; Middle Aged; Olanzapine; Palonosetron; Psychomotor Agitation; Quetiapine Fumarate; Sleep Initiation and Maintenance Disorders; Vomiting | 2022 |
Treatment of severe tardive dyskinesia with concurrent administration of olanzapine, clonazepam, baclofen, and gabapentin: a case report.
Topics: Adolescent; Antipsychotic Agents; Baclofen; Clonazepam; Female; Gabapentin; Humans; Olanzapine; Tardive Dyskinesia | 2023 |